Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vertex Pharmaceuticals
Vertex Pharmaceuticals
Coronations for New Drug Royalty
Motley Fool
Sat, 04/30/11 - 09:49 am
Vertex Pharmaceuticals
Cell Therapeutics
Telaprevir
hepatitis C
Has Vertex Peaked?
Minyanville
Fri, 04/29/11 - 12:11 pm
Vertex Pharmaceuticals
hepatitis C
Telaprevir
FDA panel unanimously favors approval for experimental hepatitis drug from Vertex Pharma
Yahoo/AP
Thu, 04/28/11 - 10:01 pm
FDA
Vertex Pharmaceuticals
advisory panels
hepatitis C
Telaprevir
Vertex: FDA Hep C Panel Live Blog
TheStreet.com
Thu, 04/28/11 - 09:00 am
Vertex Pharmaceuticals
Telaprevir
FDA
advisory panels
hepatitis C
Merck: FDA Hep C Panel Live Blog
TheStreet.com
Wed, 04/27/11 - 11:11 am
Merck
advisory panels
FDA
hepatitis C
Vertex Pharmaceuticals
Boceprevir
Vertex, Merck Step Up to the Public Stage With Hepatitis C Drugs This Week
Motley Fool
Mon, 04/25/11 - 11:15 am
Vertex Pharmaceuticals
Merck
Boceprevir
Telaprevir
hepatitis C
Merck, Vertex Prep for Hep C Drug Panels
TheStreet.com
Thu, 04/21/11 - 09:21 am
Merck
Vertex Pharmaceuticals
hepatitis C
FDA
Boceprevir
Telaprevir
advisory panels
Vertex Receives Good News on Hepatitis C Treatment
Seeking Alpha
Thu, 04/14/11 - 11:01 am
Vertex Pharmaceuticals
hepatitis C
Telaprevir
Merck
bacepravir
Victrella
Vertex Pharmaceuticals: Telaprevir a Likely Lock for Approval
Seeking Alpha
Mon, 04/11/11 - 02:29 pm
hepatitis C
Vertex Pharmaceuticals
Telaprevir
Dendreon
Forest Labs
Orexigen
Biotech Stock Mailbag: Hep C Stock Winners
TheStreet.com
Fri, 04/8/11 - 10:56 am
hepatitis C
Pharmasset
Merck
Optimer
Vertex Pharmaceuticals
Gilead Sciences
JNJ
InterMune
Bristol-Myers Squibb
Valeant CEO Spurns Drug Research for Deals With Cephalon Fight
Bloomberg
Thu, 04/7/11 - 09:17 am
Vertex Pharmaceuticals
R&D
M&A
Cephalon
Pharma CEOs
J. Michael Pearson
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 04/4/11 - 11:06 pm
Gilead Sciences
Exelixis
Amgen
Dendreon
Immunogen
Maxygen
MannKind
PDL Biopharma
Celgene
Geron
Vertex Pharmaceuticals
Arena Pharmaceuticals
Human Genome Sciences
Orexigen
Biogen Idec
Merck, J&J’s New Hepatitis C Treatments Fetch $31,000 in France
Bloomberg
Mon, 04/4/11 - 08:34 am
Merck
JNJ
hepatitis C
France
Vertex Pharmaceuticals
Telaprevir
Boceprevir
Positive Data for Vertex HCV Drug
Yahoo/Zacks
Sat, 04/2/11 - 10:23 am
Vertex Pharmaceuticals
VX-222
HCV
Vertex Pharmaceuticals' potential hepatitis C treatment meets safety goal in midstage study
Yahoo/AP
Thu, 03/31/11 - 12:27 pm
hepatitis C
Vertex Pharmaceuticals
VX-222
Vertex Notches Another Victory
Minyanville
Tue, 03/29/11 - 11:36 am
Vertex Pharmaceuticals
cystic fibrosis
VX-770
Vertex's Treatment for Cystic Fibrosis
Bloomberg Businessweek
Fri, 03/18/11 - 09:03 am
cystic fibrosis
Vertex Pharmaceuticals
VX-770
Who Will Win the Hepatitis C Market?
Seeking Alpha
Mon, 03/14/11 - 10:44 am
hepatitis C
Gilead Sciences
Merck
Bristol-Myers Squibb
Novartis
Pfizer
Vertex Pharmaceuticals
Pharmasset
Inhibitex Ready for a Breakout Year
Seeking Alpha
Fri, 03/11/11 - 12:55 pm
Inhibitex
JNJ
Merck
Pfizer
Vertex Pharmaceuticals
Vertex epilepsy drug meets key midstage study goal
Yahoo/AP
Thu, 03/10/11 - 06:02 pm
epilepsy
Vertex Pharmaceuticals
VX-765
Pages
« first
‹ previous
…
25
26
27
28
29
30
31
32
33
next ›
last »